220 related articles for article (PubMed ID: 9278198)
1. The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis.
van Miert MM; Eastwood NB; Boyd AH; Parker CJ; Hunter JM
Br J Clin Pharmacol; 1997 Aug; 44(2):139-44. PubMed ID: 9278198
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of rocuronium in patients with cirrhosis.
Khalil M; D'Honneur G; Duvaldestin P; Slavov V; De Hys C; Gomeni R
Anesthesiology; 1994 Jun; 80(6):1241-7. PubMed ID: 8010470
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of rocuronium after bolus and continuous infusion during halothane anaesthesia.
McCoy EP; Mirakhur RK; Maddineni VR; Wierda JM; Proost JH
Br J Anaesth; 1996 Jan; 76(1):29-33. PubMed ID: 8672375
[TBL] [Abstract][Full Text] [Related]
4. Repeated doses of rocuronium bromide administered to cirrhotic and control patients receiving isoflurane. A clinical and pharmacokinetic study.
Servin FS; Lavaut E; Kleef U; Desmonts JM
Anesthesiology; 1996 May; 84(5):1092-100. PubMed ID: 8624003
[TBL] [Abstract][Full Text] [Related]
5. Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK/PD analysis.
Woloszczuk-Gebicka B; Wyska E; Grabowski T
Paediatr Anaesth; 2007 Jul; 17(7):637-46. PubMed ID: 17564645
[TBL] [Abstract][Full Text] [Related]
6. Rocuronium pharmacokinetic-pharmacodynamic relationship under stable propofol or isoflurane anesthesia.
Dragne A; Varin F; Plaud B; Donati F
Can J Anaesth; 2002 Apr; 49(4):353-60. PubMed ID: 11927473
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of rocuronium in patients with and without renal failure.
Robertson EN; Driessen JJ; Booij LH
Eur J Anaesthesiol; 2005 Jan; 22(1):4-10. PubMed ID: 15816565
[TBL] [Abstract][Full Text] [Related]
8. Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide (Org 9426) during isoflurane anaesthesia in patients with and without renal failure.
Cooper RA; Maddineni VR; Mirakhur RK; Wierda JM; Brady M; Fitzpatrick KT
Br J Anaesth; 1993 Aug; 71(2):222-6. PubMed ID: 8123396
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics and pharmacokinetics of rocuronium in intensive care patients.
Sparr HJ; Wierda JM; Proost JH; Keller C; Khuenl-Brady KS
Br J Anaesth; 1997 Mar; 78(3):267-73. PubMed ID: 9135303
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacokinetic-dynamic modelling of rocuronium in infants and children.
Wierda JM; Meretoja OA; Taivainen T; Proost JH
Br J Anaesth; 1997 Jun; 78(6):690-5. PubMed ID: 9215021
[TBL] [Abstract][Full Text] [Related]
11. [Neuromuscular blocking effects, pharmacokinetics and safety of Org 9426 (rocuronium bromide) in Japanese patients].
Suzuki T; Saeki S; Takeda J; Ozaki M; Iwao Y
Masui; 2006 Apr; 55(4):419-27. PubMed ID: 16634542
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic-pharmacodynamic relationship of rocuronium under stable nitrous oxide-fentanyl or nitrous oxide-sevoflurane anesthesia in children.
Woloszczuk-Gebicka B; Wyska E; Grabowski T; Swierczewska A; Sawicka R
Paediatr Anaesth; 2006 Jul; 16(7):761-8. PubMed ID: 16879519
[TBL] [Abstract][Full Text] [Related]
13. The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl.
Wierda JM; Kleef UW; Lambalk LM; Kloppenburg WD; Agoston S
Can J Anaesth; 1991 May; 38(4 Pt 1):430-5. PubMed ID: 1829656
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of rocuronium (Org 9426) in elderly surgical patients.
Matteo RS; Ornstein E; Schwartz AE; Ostapkovich N; Stone JG
Anesth Analg; 1993 Dec; 77(6):1193-7. PubMed ID: 8250312
[TBL] [Abstract][Full Text] [Related]
15. Potency and time course of action of rocuronium during desflurane and isoflurane anaesthesia.
Kumar N; Mirakhur RK; Symington MJ; McCarthy GJ
Br J Anaesth; 1996 Oct; 77(4):488-91. PubMed ID: 8942333
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of rocuronium bromide in obese female patients.
Pühringer FK; Keller C; Kleinsasser A; Giesinger S; Benzer A
Eur J Anaesthesiol; 1999 Aug; 16(8):507-10. PubMed ID: 10500937
[TBL] [Abstract][Full Text] [Related]
17. Rocuronium pharmacokinetics and pharmacodynamics in the adductor pollicis and masseter muscles.
Vega EA; Ibacache ME; Anderson BJ; Holford NH; Nazar CE; Solari S; Allende FA; Cortínez LI
Acta Anaesthesiol Scand; 2016 Jul; 60(6):734-46. PubMed ID: 26899676
[TBL] [Abstract][Full Text] [Related]
18. [The effects of cimetidine on the pharmacodynamics of rocuronium].
Latorre F; de Almeida MC; Stanek A; Weiler N; Kleemann PP
Anaesthesist; 1996 Oct; 45(10):900-2. PubMed ID: 8992903
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of rocuronium bromide in hepatic cirrhosis.
Hunter JM
Eur J Anaesthesiol Suppl; 1995 Sep; 11():39-41. PubMed ID: 8557004
[TBL] [Abstract][Full Text] [Related]
20. Neuromuscular effects of rocuronium on the diaphragm and adductor pollicis muscles in anesthetized patients.
Cantineau JP; Porte F; d'Honneur G; Duvaldestin P
Anesthesiology; 1994 Sep; 81(3):585-90. PubMed ID: 8092503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
